BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27535684)

  • 21. Comparison of Transcription-Mediated Amplification and Real-Time PCR Assays for Hepatitis B Virus DNA Quantitation in Serum.
    Weber J; Sahoo MK; Taylor N; Uy E; Shi RZ; Pinsky BA
    J Appl Lab Med; 2019 Nov; 4(3):383-390. PubMed ID: 31659075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analytical performance of the Hologic Aptima HBV Quant Assay and the COBAS Ampliprep/COBAS TaqMan HBV test v2.0 for the quantification of HBV DNA in plasma samples.
    Schønning K; Johansen K; Nielsen LG; Weis N; Westh H
    J Clin Virol; 2018 Jul; 104():83-88. PubMed ID: 29783147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicenter Evaluation of Two Next-Generation HIV-1 Quantitation Assays, Aptima Quant Dx and Cobas 6800, in Comparison to the RealTi
    Wiesmann F; Ehret R; Naeth G; Däumer M; Fuhrmann J; Kaiser R; Noah C; Obermeier M; Schalasta G; Tiemann C; Wolf E; Knechten H; Braun P
    J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30068537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective evaluation of accuracy of HIV viral load monitoring using the Aptima HIV Quant Dx assay with fingerstick and venous dried blood spots prepared under field conditions in Kenya.
    Mwau M; Danda J; Mbugua J; Handa A; Fortunko J; Worlock A; Nair SV
    PLoS One; 2021; 16(4):e0249376. PubMed ID: 33798221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Separation of Plasma from Whole Blood by Use of the cobas Plasma Separation Card: a Compelling Alternative to Dried Blood Spots for Quantification of HIV-1 Viral Load.
    Carmona S; Seiverth B; Magubane D; Hans L; Hoppler M
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30728197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of dilution of plasma samples with phosphate buffered saline to eliminate the problem of small volumes associated with children infected with HIV-1 for viral load testing using Cobas AmpliPrep/COBAS TaqMan HIV-1 test, version 2.0 (CAP CTM HIV v2.0).
    Mine M; Nkoane T; Sebetso G; Sakyi B; Makhaola K; Gaolathe T
    J Virol Methods; 2013 Dec; 194(1-2):217-21. PubMed ID: 24025342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of the New Aptima HCV Quant Dx Assay in Comparison to the Cobas TaqMan HCV2 Test for Use with the High Pure System in Detection and Quantification of Hepatitis C Virus RNA in Plasma or Serum.
    Schalasta G; Speicher A; Börner A; Enders M
    J Clin Microbiol; 2016 Apr; 54(4):1101-7. PubMed ID: 26865682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing Abbott m2000 RealTime HIV test and Roche COBAS Ampliprep/COBAS Taqman HIV test, v2.0 in treated HIV-1 B and non-B subjects with low viraemia.
    Margariti A; Chatzidimitriou D; Metallidis S; Pilalas D; Kourelis A; Papadimitriou E; Haidich AB; Malisiovas N; Skoura L
    J Med Virol; 2016 Apr; 88(4):724-7. PubMed ID: 26331699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical performance evaluation of the Aptima viral assays for the quantitation of HIV-1, HCV, and HBV in plasma samples.
    Lewis S; Morehead E; Cheung H; Mostafa HH
    Diagn Microbiol Infect Dis; 2023 Jul; 106(3):115951. PubMed ID: 37127022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative evaluation of the Aptima HIV-1 Quant Dx assay and COBAS TaqMan HIV-1 v2.0 assay using the Roche High Pure System for the quantification of HIV-1 RNA in plasma.
    Schalasta G; Börner A; Speicher A; Enders M
    Clin Chem Lab Med; 2016 Mar; 54(3):493-9. PubMed ID: 26351942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limited utility of dried-blood- and plasma spot-based screening for antiretroviral treatment failure with Cobas Ampliprep/TaqMan HIV-1 version 2.0.
    Sawadogo S; Shiningavamwe A; Chang J; Maher AD; Zhang G; Yang C; Gaeb E; Kaura H; Ellenberger D; Lowrance DW
    J Clin Microbiol; 2014 Nov; 52(11):3878-83. PubMed ID: 25143579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analytical and clinical performance of the Hologic Aptima HCV Quant Dx Assay for the quantification of HCV RNA in plasma samples.
    Schønning K; Pedersen MS; Johansen K; Landt B; Nielsen LG; Weis N; Westh H
    J Virol Methods; 2017 Oct; 248():159-165. PubMed ID: 28732692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance of a Novel Low-Cost, Instrument-Free Plasma Separation Device for HIV Viral Load Quantification and Determination of Treatment Failure in People Living with HIV in Malaysia: a Diagnostic Accuracy Study.
    Pham MD; Haile BA; Azwa I; Kamarulzaman A; Raman N; Saeidi A; Kahar Bador M; Tan M; Zhu J; Feng Y; Elliott JH; Garcia ML; Li F; Crowe SM; Luchters S; Anderson DA
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30700508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance evaluation of the Hologic Aptima HCV Quant Dx assay for detection of HCV RNA from dried blood spots.
    Catlett B; Carrera A; Starr M; Applegate TL; Lowe P; Grebely J; Philip Cunningham H
    J Clin Virol; 2019 Mar; 112():40-44. PubMed ID: 30776575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Simple Phosphate-Buffered-Saline-Based Extraction Method Improves Specificity of HIV Viral Load Monitoring Using Dried Blood Spots.
    Makadzange AT; Boyd FK; Chimukangara B; Masimirembwa C; Katzenstein D; Ndhlovu CE
    J Clin Microbiol; 2017 Jul; 55(7):2172-2179. PubMed ID: 28468852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correction of underquantification of human immunodeficiency virus type 1 load with the second version of the Roche Cobas AmpliPrep/Cobas TaqMan assay.
    De Bel A; Marissens D; Debaisieux L; Liesnard C; Van den Wijngaert S; Lauwers S; Piérard D
    J Clin Microbiol; 2010 Apr; 48(4):1337-42. PubMed ID: 20164284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance evaluation of the Aptima
    Garbuglia AR; Bibbò A; Sciamanna R; Pisciotta M; Capobianchi MR
    J Clin Virol; 2017 Jul; 92():1-6. PubMed ID: 28475925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between the automated Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 assay and its version 1 and Nuclisens HIV-1 EasyQ version 2.0 assays when measuring diverse HIV-1 genotypes in China.
    Xu S; Song A; Nie J; Li X; Meng S; Zhang C; Wang Y
    J Clin Virol; 2012 Jan; 53(1):33-7. PubMed ID: 22051503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the QIAGEN artus HIV-1 QS-RGQ test with the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 test v2.0.
    Wall GR; Perinpanathan D; Clark DA
    J Clin Virol; 2012 Sep; 55(1):62-6. PubMed ID: 22739101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Field Evaluation of Dried Blood Spots for HIV-1 Viral Load Monitoring in Adults and Children Receiving Antiretroviral Treatment in Kenya: Implications for Scale-up in Resource-Limited Settings.
    Schmitz ME; Agolory S; Junghae M; Broyles LN; Kimeu M; Ombayo J; Umuro M; Mukui I; Alwenya K; Baraza M; Ndiege K; Mwalili S; Rivadeneira E; Ngʼangʼa L; Yang C; Zeh C;
    J Acquir Immune Defic Syndr; 2017 Apr; 74(4):399-406. PubMed ID: 28002185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.